Christopher Kobylecki is a Consultant Neurologist at Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust and Honorary Senior Lecturer in Neuroscience at the University of Manchester.
He undertook postdoctoral research focused on the use of positron emission tomography (PET) and MR imaging in parkinsonian syndromes such as multiple system atrophy and neurodegenerative dementias.
He runs a specialist Movement Disorder clinic at Salford Royal and is lead for the regional service for patients with atypical parkinsonism, as well as being a lead for medical advanced therapies i.e. apomorphine and Duodopa. His research interests include motor complications of PD, cognitive and non-motor disorders in PD and atypical parkinsonism, and dystonia.
Chris is the newly appointed chair of the Scientific Advisory Panel.